Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
US says parties can still walk away from Iran deal, sequencing will be key
Trump threatens to resume bombing ahead of Iran peace deal signing
Qantas picks London for first record-breaking non-stop flights
G7 leaders demand ceasefire in Lebanon, welcome Iran deal
Trump: Iran deal 'loud and clear' that Tehran won't have nuclear weapon
